Gelonghui May 5 丨 Sunflower Pharmaceutical (002737)(002737donkeykongjr.SZ) AnnouncementdonkeykongjrHarbin Kuihua Pharmaceutical Co., Ltd.(hereinafter referred to as "Harbin Kuihua"), a wholly-owned subsidiary of the company, recently received a issuance from the State Drug Administration.donkeykongjrThe Acceptance Notice on the Application for Registration and Marketing Authorization of Compound Polyethylene Glycol (3350) Electrolyte Powder. Proposed indications (or functional indications) of the drug: For the treatment of chronic constipation in children aged 1 to 11 years and fecal impaction in children aged 5 to 11 years.